STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Octagon and Ting Jia Disclose 7.8% Stake in Unicycive (UNCY)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Octagon Capital Advisors LP and related funds and principal Ting Jia report beneficial ownership of 1,000,000 shares of Unicycive Therapeutics, Inc. (UNCY), representing 7.8% of the outstanding common stock based on 12,768,239 shares outstanding as reported by the issuer. Octagon is the investment manager of the funds and Mr. Jia is the managing member of Octagon, and by virtue of those relationships Octagon and Mr. Jia may be deemed to beneficially own the shares held by the funds.

The filing discloses that the reported holdings are held with shared voting and dispositive power rather than sole power. The ownership is allocated as 650,000 shares (5.1%) held by Octagon Investments Master Fund LP and 350,000 shares (2.7%) held by Octagon Private Opportunities Fund II LP. The filing includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Positive

  • Material disclosure: A combined stake of 1,000,000 shares equals 7.8% of UNCY, exceeding the 5% reporting threshold.
  • Clear allocation: Holdings are broken down by fund: 650,000 shares (5.1%) for the Master Fund and 350,000 shares (2.7%) for Private Fund II, improving transparency.

Negative

  • No sole control: All reported voting and dispositive powers are shared (sole power reported as 0), indicating no direct control by the reporting persons.
  • Held on behalf of investors: The funds hold the shares for their investors, meaning the economic interest is indirect rather than personal.

Insights

TL;DR Octagon and affiliates hold 7.8% of UNCY through funds, a material stake that signals investor interest but not control.

The Schedule 13G/A shows a combined beneficial ownership of 1,000,000 shares, equal to 7.8% of the outstanding common stock based on 12,768,239 shares. The reporting structure is fund-centric: 650,000 shares are held by the Master Fund and 350,000 by Private Fund II, with Octagon acting as investment manager and Mr. Jia as managing member. All voting and dispositive powers disclosed are shared rather than sole, which means the position is meaningful but does not convey direct control. The filing also affirms acquisition in the ordinary course of business.

TL;DR A >5% aggregated holding is reportable and material; governance impact appears limited because power is shared and not sole.

The document identifies joint filing by Octagon entities and Ting Jia and discloses shared voting and dispositive power for the reported positions. Because the reporting persons disclaim sole voting power, the stake is significant under disclosure rules but does not indicate an expressed intent to change board composition or control. The certification attesting ordinary-course acquisition further supports a passive, disclosure-driven filing rather than an activist posture.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Octagon Capital Advisors LP
Signature:/s/ Ting Jia
Name/Title:Managing Member
Date:08/12/2025
Octagon Investments Master Fund LP
Signature:/s/ Ting Jia
Name/Title:Managing Member, Octagon Investments GP, LLC, its general partner
Date:08/12/2025
Octagon Private Opportunities Fund II LP
Signature:/s/ Ting Jia
Name/Title:Managing Member, Octagon Investments GP, LLC, its general partner
Date:08/12/2025
Ting Jia
Signature:/s/ Ting Jia
Name/Title:Ting Jia
Date:08/12/2025

FAQ

How many Unicycive (UNCY) shares do Octagon and affiliates report owning?

The reporting persons disclose beneficial ownership of 1,000,000 shares of UNCY, representing 7.8% of the class.

What is the breakdown of the 1,000,000 shares reported for UNCY?

Octagon Investments Master Fund LP holds 650,000 shares (5.1%) and Octagon Private Opportunities Fund II LP holds 350,000 shares (2.7%).

Do the reporting persons have sole voting or dispositive power over the UNCY shares?

No. The filing reports 0 shares with sole voting or dispositive power and all reported powers are shared.

Was the UNCY position acquired to influence control of the company?

The filing includes a certification stating the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control.

On what share count is the 7.8% figure based for UNCY?

The percentage is calculated using 12,768,239 common shares outstanding as reported by the issuer.
Unicycive Therapeutics Inc

NASDAQ:UNCY

UNCY Rankings

UNCY Latest News

UNCY Latest SEC Filings

UNCY Stock Data

125.94M
17.03M
3.56%
31.05%
7.26%
Biotechnology
Pharmaceutical Preparations
Link
United States
LOS ALTOS